Literature DB >> 10417783

Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening.

M F Ritz1, B Erne, F Ferracin, A Vital, C Vital, A J Steck.   

Abstract

The purpose of this study was to evaluate the relationship between immunoglobulin M (IgM) antibodies penetration into myelinated peripheral nerve fibers and the widening of the peripheral myelin sheaths in anti-myelin-associated glycoprotein (anti-MAG) demyelinating IgM monoclonal polyneuropathy. Demyelinating polyneuropathy with monoclonal IgM is often associated with anti-MAG autoantibodies, which are thought to initiate the disease with IgM deposits usually present on the myelin sheaths. We analyzed nerve biopsies from 12 patients with an anti-MAG demyelinating neuropathy by confocal and electron microscopy. The total number of nerve fibers and the proportion of IgM-associated fibers were quantified after immunohistochemical staining. The affinities of IgM were examined by analyzing the binding pattern of serum IgM on normal peripheral nerve sections. Ultrastructural examinations of the biopsies showed a good correlation between in situ widened myelin sheaths and the IgM penetration level into myelinated fibers. The terminal complement complex appears not be involved in the penetration of IgM into the myelinated fibers. Our findings suggest a causative role of the IgM anti-MAG antibodies in the ultrastructural modifications of the myelin sheaths. The basement membrane and myelin components appear to be the major targets of the IgM monoclonal antibodies. However, the pathogenic mechanism whereby IgM antibodies reach their targets and induce nerve damage are still unclear. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417783     DOI: 10.1002/(sici)1097-4598(199908)22:8<1030::aid-mus4>3.0.co;2-h

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

Review 1.  Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptake.

Authors:  Sabrina Lisi; Margherita Sisto; Dario Domenico Lofrumento; Simona D'Amore; Massimo D'Amore
Journal:  Clin Exp Med       Date:  2010-05-09       Impact factor: 3.984

2.  Pathogenesis and treatment of immune-mediated neuropathies.

Authors:  Helmar C Lehmann; Gerd Meyer Zu Horste; Bernd C Kieseier; Hans-Peter Hartung
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

Review 3.  Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.

Authors:  Luis Querol; Jérôme Devaux; Ricard Rojas-Garcia; Isabel Illa
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

4.  Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen-specific treatment option for anti-MAG neuropathy.

Authors:  Ruben Herrendorff; Pascal Hänggi; Hélène Pfister; Fan Yang; Delphine Demeestere; Fabienne Hunziker; Samuel Frey; Nicole Schaeren-Wiemers; Andreas J Steck; Beat Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-17       Impact factor: 11.205

Review 5.  Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.

Authors:  Einar M Sigurdsson
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

6.  Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection.

Authors:  Vijay Khiani; Thomas Kelly; Adeel Shibli; Donald Jensen; Smruti R Mohanty
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

7.  Entrapment in anti myelin-associated glycoprotein neuropathy.

Authors:  Catharina G Faber; Nicolette C Notermans; John H J Wokke; Hessel Franssen
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

8.  Alcohol Misuse Link to POEMS Syndrome in a Patient.

Authors:  John Neary; Susan E Goodwin; Lawrence B Cohen; Manuela G Neuman
Journal:  Cancers (Basel)       Date:  2017-09-23       Impact factor: 6.639

9.  Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen-specific glycopolymer.

Authors:  Butrint Aliu; Delphine Demeestere; Emilie Seydoux; José Boucraut; Emilien Delmont; Alexandre Brodovitch; Thomas Oberholzer; Shahram Attarian; Marie Théaudin; Pinelopi Tsouni; Thierry Kuntzer; Tobias Derfuss; Andreas J Steck; Beat Ernst; Ruben Herrendorff; Pascal Hänggi
Journal:  J Neurochem       Date:  2020-06-23       Impact factor: 5.372

Review 10.  Complement in neurological disorders and emerging complement-targeted therapeutics.

Authors:  Marinos C Dalakas; Harry Alexopoulos; Peter J Spaeth
Journal:  Nat Rev Neurol       Date:  2020-10-01       Impact factor: 42.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.